Clinical trial
Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma
NCT02494700 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- July 6, 2015
- Completion date
- June 30, 2027
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ann arbor stage i b-cell non-hodgkin lymphoma, ann arbor stage i grade 1 follicular lymphoma, ann arbor stage i grade 2 follicular lymphoma, ann arbor stage i indolent adult non-hodgkin lymphoma, ann arbor stage i mantle cell lymphoma, ann arbor stage ii b-cell non-hodgkin lymphoma, ann arbor stage ii grade 1 follicular lymphoma, ann arbor stage ii grade 2 follicular lymphoma, ann arbor stage ii indolent adult non-hodgkin lymphoma, ann arbor stage ii mantle cell lymphoma, ann arbor stage iii b-cell non-hodgkin lymphoma, ann arbor stage iii grade 1 follicular lymphoma, ann arbor stage iii grade 2 follicular lymphoma, ann arbor stage iii indolent adult non-hodgkin lymphoma, ann arbor stage iii mantle cell lymphoma, ann arbor stage iv b-cell non-hodgkin lymphoma, ann arbor stage iv grade 1 follicular lymphoma, ann arbor stage iv grade 2 follicular lymphoma, ann arbor stage iv indolent adult non-hodgkin lymphoma, ann arbor stage iv mantle cell lymphoma, ocular adnexal lymphoma, ocular adnexal mucosa-associated lymphoid tissue lymphoma, orbit lymphoma